In this episode of the Forbes India cover story podcast, Naini Thaker discusses how startups are leveraging technology to overcome long-standing challenges like access and affordability in a healthcare market projected to double in the next few years. The conversation explores real-world examples, including innovative solutions for remote critical care, AI-driven diagnostics for faster results, and a path for Indian innovators that diverges from the high-spending American model

Bharat Forge, long known for its auto components, is fast emerging as a formidable force in India’s defence sector. Under Baba Kalyani’s leadership, the company has invested heavily in R&D, building capabilities in artillery, UAVs, and aerospace, while benefiting from supportive government policies. With exports beginning and new verticals taking shape, Bharat Forge is poised to transform into a defence-first enterprise in the coming years

In the latest Inside Forbes India podcast, Naini Thaker puts the spotlight on startups building for Bharat—India’s rural, small-town, and value-conscious consumers. From e-grocers mapping villages off Google Maps to CureBay’s hybrid e-clinics, SolarSquare’s tier-3 solar push, and CityMall’s micro-entrepreneur-led deliveries, these ventures tackle access, trust, language, and culture gaps. The episode shows why Bharat is the next big growth story for Indian entrepreneurship.

Ride-hailing apps are abandoning the controversial commission model in favor of a subscription model that prioritises drivers. How will the Ola vs Rapido vs Uber war play out? Naini Thaker, who authored this fortnight's cover story, gives us the details 

For the latest episode of Inside Forbes India podcast, Manu Balachandran discusses how a global shortage of rare earth magnets that are critical to EVs and electronics is threatening India’s auto industry. With China dominating supply, geopolitical tensions, and Trump tariffs disrupting imports, automakers face short-term uncertainty and long-term questions about self-reliance.

In the latest episode of the Inside Forbes India podcast, Naini Thaker talks about the new special, which explores India’s evolving startup landscape. While consumer tech thrives, deep tech is emerging, driven by founders tackling unique Indian challenges. From InMobi’s AI pivot to EV tractors by Moonrider and rapid-charging batteries by Exponent Energy, Indian startups are innovating for scale. The podcast discusses how optimism and patient capital are fueling a new wave of ambitious entrepreneurs.

Homegrown innovators, policymakers, and startups are laying the groundwork for an AI future where Indian languages, datasets and social context will shape the future of AI. Forbes India's Naini Thaker unpacks our AI special which has identified 30 Indians who are leading the revolution in their own fields

In this special edition of the Inside Forbes India Podcast, Kunal Purandare discusses the magazine's 16th anniversary issue, themed around disruption. The episode explores essays on India's resilience to global shocks, the rise of longevity science, AI's evolving role in work, why sport matters beyond medals and much more. The edition takes stock of India's present and future potential with insights from leaders like Abhinav Bindra, Sanjeev Bikhchandani, and Rohan Murty.

In the latest episode of the Inside Forbes India podcast, Salil Panchal discusses Axis Bank's transformation under CEO Amitabh Chaudhry. From bold leadership shifts to the pivotal acquisition of Citibank's India consumer business, Axis Bank is now scaling up in credit cards and wealth management. Chaudhry's hands-on yet non-micromanaging style, focus on tech, and clear sector priorities are driving growth. With his term running till 2027, the bank has time to sharpen its edge.

In the latest episode of Inside Forbes India Podcast, Naini Thaker discusses her deep-dive profile on Dilip Shanghvi, the low-key founder of Sun Pharma, India's largest pharmaceutical company. Starting with just $200, Shanghvi's strategic focus on chronic therapies and high-value acquisitions—most notably Ranbaxy—helped shape Sun Pharma into a global force. The conversation explores how the company weathered challenges, such as price erosion, by doubling down on R&D and pivoting toward complex speciality drugs. It also highlights that Shanghvi's leadership is marked by humility, passion for his work, and a focus on patient care rather than wealth accumulation.